Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients

Author:

Pavlovic Jelena M1,Yu Justin S2,Silberstein Stephen D3,Reed Michael L4,Kawahara Steve H5,Cowan Robert P6,Dabbous Firas7,Campbell Karen L2,Shewale Anand R2,Pulicharam Riya5,Kowalski Jonathan W2,Viswanathan Hema N2,Lipton Richard B8

Affiliation:

1. Montefiore Headache Center, Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA

2. Allergan plc, Irvine, CA, USA

3. Jefferson Headache Center, Philadelphia, PA, USA

4. Vedanta Research, Chapel Hill, NC, USA

5. DaVita Medical Group, El Segundo, CA, USA

6. Stanford University School of Medicine, Stanford, CA, USA

7. Independent consultant, La Jolla, CA, USA

8. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA

Abstract

Objective To develop a claims-based algorithm to identify undiagnosed chronic migraine among patients enrolled in a healthcare system. Methods An observational study using claims and patient survey data was conducted in a large medical group. Eligible patients had an International Classification of Diseases, Ninth/Tenth Revision (ICD-9/10) migraine diagnosis, without a chronic migraine diagnosis, in the 12 months before screening and did not have a migraine-related onabotulinumtoxinA claim in the 12 months before enrollment. Trained clinicians administered a semi-structured diagnostic interview, which served as the gold standard to diagnose chronic migraine, to enrolled patients. Potential claims-based predictors of chronic migraine that differentiated semi-structured diagnostic interview-positive (chronic migraine) and semi-structured diagnostic interview-negative (non-chronic migraine) patients were identified in bivariate analyses for inclusion in a logistic regression model. Results The final sample included 108 patients (chronic migraine = 64; non-chronic migraine = 44). Four significant predictors for chronic migraine were identified using claims in the 12 months before enrollment: ≥15 versus <15 claims for acute treatment of migraine, including opioids (odds ratio = 5.87 [95% confidence interval: 1.34–25.63]); ≥24 versus <24 healthcare visits (odds ratio = 2.80 [confidence interval: 1.08–7.25]); female versus male sex (odds ratio = 9.17 [confidence interval: 1.26–66.50); claims for ≥2 versus 0 unique migraine preventive classes (odds ratio = 4.39 [confidence interval: 1.19–16.22]). Model sensitivity was 78.1%; specificity was 72.7%. Conclusions The claims-based algorithm identified undiagnosed chronic migraine with sufficient sensitivity and specificity to have potential utility as a chronic migraine case-finding tool using health claims data. Research to further validate the algorithm is recommended.

Funder

Allergan plc

Publisher

SAGE Publications

Subject

Clinical Neurology,General Medicine

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3